{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:15:39Z","timestamp":1787318139731,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Pediatric oncology patients, who are typically immunosuppressed, exposed to medications associated with increased\n                      <jats:italic toggle=\"yes\">Clostridioides difficile<\/jats:italic>\n                      infection (CDI) risk and hospitalized, are expected to be at substantial risk for infection and complications. Although certain\n                      <jats:italic toggle=\"yes\">C. difficile<\/jats:italic>\n                      ribotypes have been associated with more severe infection in adults, such an association has not been described in children.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>To characterize CDI epidemiology, including risk factors and complications among pediatric oncology patients, we retrospectively reviewed charts of patients 1\u201318 years old treated at a designated cancer center during 2000\u20132017. We used fluorescence-based polymerase chain reaction to identify ribotypes causing disease at our institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In 11,366 total patients, we identified 207 CDI cases during the study period. CDI prevalence in our pediatric oncology population was 18 cases per 1000 patients. CDI was highest among patients with acute myeloid leukemia, neuroblastoma, and desmoplastic small round cell tumor (105, 66 and 111 cases per 1000 patients, respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Fever, leukocytosis, elevated creatinine and abdominal radiation and fluoroquinolone exposure concurrent with treatment of CDI were associated with complications. Patients with severe CDI experienced increased mortality. Ribotypes previously associated with severe infection were observed infrequently and were not associated with mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This is the largest study of CDI in pediatric oncology patients to date. The study identifies specific oncologic diagnoses with increased CDI risk and factors predictive of poor outcomes. As CDI treatment guidelines are developed for this population, these data will be useful for risk stratification of patients in need of early, aggressive treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004178","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T17:00:09Z","timestamp":1703264409000},"page":"136-141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9396-5842","authenticated-orcid":false,"given":"Brianna R.","family":"Murphy","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Dailey Garnes","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics"},{"name":"Department of Infectious Diseases, Infection Control, and Employee Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsoo","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W.","family":"Garey","sequence":"additional","affiliation":[{"name":"Pharmacy Practice and Translational Research, The University of Houston College of Pharmacy, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Okhuysen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/INF.0000000000000338","article-title":"A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.","volume":"33","author":"Crews","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/INF.0000000000000767","article-title":"Risk factors for community-associated Clostridium difficile-associated diarrhea in children.","volume":"34","author":"Crews","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/jpids\/piab057","article-title":"Molecular epidemiology of Clostridioides difficile infections in children.","volume":"10","author":"Perumalsamy","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/cid\/ciu302","article-title":"High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients.","volume":"59","author":"Dominguez","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"19403","DOI":"10.2807\/ese.14.45.19403-en","article-title":"Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany.","volume":"14","author":"Arvand","year":"2009","journal-title":"Euro Surveill"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3201\/eid1604.090680","article-title":"Clostridium difficile infections among hospitalized children, United States, 1997-2006.","volume":"16","author":"Zilberberg","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/jpids\/piab078","article-title":"Epidemiology, diagnosis, and treatment of Clostridioides difficile infection in immunocompromised children.","volume":"10","author":"Cross","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/157489112801619674","article-title":"The evolution of Clostridium difficile infection in cancer patients: epidemiology, pathophysiology, and guidelines for prevention and management.","volume":"7","author":"Khan","year":"2012","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jpids\/piaa090","article-title":"Clostridioides difficile infections in inpatient pediatric oncology patients: a cohort study evaluating risk factors and associated outcomes.","volume":"10","author":"Willis","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.3748\/wjg.v16.i28.3573","article-title":"Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.","volume":"16","author":"Kim","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1574-6968.1999.tb13629.x","article-title":"Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing.","volume":"175","author":"Bidet","year":"1999","journal-title":"FEMS Microbiol Lett"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12879-017-2553-z","article-title":"Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in the United States community hospitals.","volume":"17","author":"Delgado","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jpids\/piaa090","article-title":"Clostridioides difficile infections in inpatient pediatric oncology patients: a cohort study evaluating risk factors and associated outcomes.","volume":"10","author":"Willis","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00431-017-3070-1","article-title":"Investigation of Clostridium difficile ribotypes in symptomatic patients of a German pediatric oncology center.","volume":"177","author":"Simon","year":"2018","journal-title":"Eur J Pediatr"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/INF.0b013e31820970d1","article-title":"Clostridium difficile infection among children with cancer.","volume":"30","author":"Tai","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/21548331.2018.1533673","article-title":"Clostridium difficile infection in oncology patients: epidemiology, pathophysiology, risk factors, diagnosis, and treatment.","volume":"46","author":"Abughanimeh","year":"2018","journal-title":"Hosp Pract (1995)"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/clinids\/17.1.109","article-title":"Clostridium difficile infection associated with antineoplastic chemotherapy: a review.","volume":"17","author":"Anand","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/adc.72.3.219","article-title":"Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit.","volume":"72","author":"Schuller","year":"1995","journal-title":"Arch Dis Child"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/668023","article-title":"Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report.","volume":"33","author":"Kamboj","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00277-009-0772-0","article-title":"Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia.","volume":"89","author":"Schalk","year":"2010","journal-title":"Ann Hematol"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1748-717X-6-89","article-title":"Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?","volume":"6","author":"Hautmann","year":"2011","journal-title":"Radiat Oncol"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"e82659","DOI":"10.1371\/journal.pone.0082659","article-title":"Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing.","volume":"8","author":"Nam","year":"2013","journal-title":"PLoS One"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/nu10101405","article-title":"The microbiome and radiation induced-bowel injury: evidence for potential mechanistic role in disease pathogenesis.","volume":"10","author":"Kumagai","year":"2018","journal-title":"Nutrients"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13017-019-0228-3","article-title":"2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.","volume":"14","author":"Sartelli","year":"2019","journal-title":"World J Emerg Surg"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.surg.2009.11.021","article-title":"Postoperative Clostridium difficile-associated diarrhea.","volume":"148","author":"Southern","year":"2010","journal-title":"Surgery"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JOP.2016.018614","article-title":"Clostridium difficile-associated diarrhea in the oncology patient.","volume":"13","author":"Neemann","year":"2017","journal-title":"J Oncol Pract"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2012.45.5899","article-title":"Resolution of Clostridium difficile\u2013associated diarrhea.","volume":"31","author":"Cornely","year":"2013","journal-title":"J Clin Oncol"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00520-014-2174-7","article-title":"Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.","volume":"22","author":"Yoon","year":"2014","journal-title":"Support Care Cancer"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/adc.63.8.979","article-title":"Clostridium difficile in an oncology unit.","volume":"63","author":"Brunetto","year":"1988","journal-title":"Arch Dis Child"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1093\/cid\/ciac459","article-title":"Molecular epidemiology and genetic relatedness of Clostridioides difficile Isolates in pediatric oncology and transplant patients using whole genome sequencing.","volume":"76","author":"Barbar","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/j.1572-0241.2008.01975.x","article-title":"Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients.","volume":"103","author":"Aseeri","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.3748\/wjg.v16.i28.3573","article-title":"Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.","volume":"16","author":"Kim","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.mayocp.2011.12.021","article-title":"Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.","volume":"87","author":"Khanna","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation.","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13756-015-0081-4","article-title":"Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients.","volume":"4","author":"Boyle","year":"2015","journal-title":"Antimicrob Resist Infect Control"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"18942","DOI":"10.2807\/ese.13.31.18942-en","article-title":"Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.","volume":"13","author":"Kuijper","year":"2008","journal-title":"Euro Surveill"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1093\/cid\/ciaa1184","article-title":"Clostridioides difficile infection in cancer and immunocompromised patients: relevance of a two-step diagnostic algorithm and infecting ribotypes on clinical outcomes.","volume":"72","author":"Yepez Guevara","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T20:02:49Z","timestamp":1749931369000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004178","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}